Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis-Reference-Cited by-同舟云学术

Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis

Published:2024-03 Issue:3 Volume:25 Page:366-375
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Gharzai Laila A,Morris Emily,Suresh Krithika,Nguyen-Tân Phuc Felix,Rosenthal David I,Gillison Maura L,Harari Paul M,Garden Adam S,Koyfman Shlomo,Caudell Jimmy J,Jones Christopher U,Mitchell Darrion L,Krempl Greg,Ridge John A,Gensheimer Michael F,Bonner James A,Filion Edith,Dunlap Neal E,Stokes William A,Le Quynh-Thu,Torres-Saavedra Pedro,Mierzwa Michelle,Schipper Matthew J

Funder

University of Michigan

NRG Oncology

Publisher

Elsevier BV

Reference30 articles.

1. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers;Gillison;J Natl Cancer Inst,2000

2. Human papillomavirus and survival of patients with oropharyngeal cancer;Ang;N Engl J Med,2010

3. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial;Gillison;Lancet,2019

4. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial;Mehanna;Lancet,2019

5. ARTSCAN III: a randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck squamous cell cancer;Gebre-Medhin;J Clin Oncol,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endpoints in human papillomavirus-related oropharyngeal cancer trials;The Lancet Oncology;2024-03